Aytu Biopharma (AYTU) Depreciation and Depletion (2010 - 2026)

Aytu Biopharma (AYTU) has 15 years of Depreciation and Depletion data on file, last reported at $100000.0 in Q1 2026.

• On a quarterly basis, Depreciation and Depletion changed 0.0% year-over-year to $100000.0 in Q1 2026; TTM through Mar 2026 was $300000.0, a 25.0% decrease from a year earlier, with the FY2025 full-year figure at $200000.0, down 77.78% from the prior year.
• Depreciation and Depletion for Q1 2026 stood at $100000.0, roughly flat from $100000.0 in the prior quarter.
• Over the last five years, Depreciation and Depletion for AYTU reached as high as $500000.0 in Q1 2022 and fell as low as $100000.0 in Q2 2024.
• Historically, Depreciation and Depletion has averaged $225000.0 across 5 years, with a median of $250000.0 in 2022.
• Across the five-year window, Depreciation and Depletion changed 0.0% in 2022 and tumbled 66.67% in 2024, its largest moves.
• Year by year, Depreciation and Depletion stood at $400000.0 in 2022, then slipped by 25.0% to $300000.0 in 2023, then slumped by 66.67% to $100000.0 in 2024, then changed by 0.0% to $100000.0 in 2025, then changed by 0.0% to $100000.0 in 2026.
• Per Business Quant data, the three most recent Depreciation and Depletion figures were $100000.0 in Q1 2026, $100000.0 in Q4 2025, and $100000.0 in Q3 2025.